Molecular mechanisms that underlie the pathogenesis and progression of malignant thyroid cancer (TC) are poorly understood. In this study, we employed network-based integrative analyses of TC lesions to identify key molecules that are possible hub genes and proteins in molecular pathways active in TC. We thus studied a microarray gene expression dataset (GSE82208, n=52) that compared TC to benign thyroid tumours (follicular thyroid adenomas) in order to identify differentially expressed genes (DEGs) in TC. We used Gene Ontology (GO) and KEGG pathway analyses to identify potential gene and pathways roles as well as candidate hub genes identified by protein-protein interaction (PPI) analysis. TC showed altered levels of 598 gene transcripts, with 133 genes up-and 465 genes down-regulated. We observed four significant pathways (One carbon pool by folate, p53 signaling, Progesterone-mediated oocyte maturation signaling and Cell cycle pathways) connected with the significantly up-regulated DEGs; eight pathways were connected with the significantly down-regulated DEGs in TC. We observed ten significant GO groups connected with the significantly up-regulated DEGs and eighty connected with the significantly down-regulated DEGs in TC. The PPI analysis identified 12 potential hub genes based on degree and betweenness centrality. These included TOP2A, JUN, EGFR, CDK1, FOS, CDKN3, EZH2, TYMS, PBK, CDH1, UBE2C and CCNB2. Moreover, transcription factors (TFs) that may influence the observed TC gene expression were identified, including FOXC1, GATA2, YY1, FOXL1, E2F1, NFIC, SRF, TFAP2A, HINFP, and CREB1. We also identified potential microRNA (miRNAs) that may also affect transcript levels of DEGs,. Thus, our study identified DEGs, molecular pathways, TFs and miRNAs that identify pathways and molecular mechanisms that may underly malignant progression in TC. These include novel candidates for further studies to identify new TC biomarkers and therapeutic targets.
I. INTRODUCTION
Thyroid cancer (TC) is the most common endocrine malignant disease [24] , and although it has a relatively low mortality rate compared to most other common metastatic diseases its incidence is rising and is now the fifth most common cancer disease in women, notably affecting those in the 20 to 34 year age range. Global incidence of thyroid cancer is increasing about 5% per year [1] , although some of this increase may be due to better detection technologies. TC prevalence in the United States in 2012 was 56,460 new diagnoses of thyroid cancer and 1,780 TC-related deaths. The disease has a particularly high incidence in Korea [13] . While TC is three times more common in women than men, the death rate is similar between the sexes due to a much higher mortality rate in men. Where the disease is localized only in the thyroid, the 5-year survival rate is over 99%, but presence of distant metastasis is a associated with a survival rate below 55%. Four major types of thyroid cancer are defined, namely medullary thyroid carcinoma (the most common, arising from parafollicaular cells), follicular thyroid carcinoma, papillary thyroid carcinoma, and anaplastic thyroid carcinoma [3] .
The causes and development processes that give rise to TC are poorly understood, and these cancers can be difficult to treat. Treatments vary by stage and type, with surgery (thyroidectomy) regarded as first line, but also including radioactive iodine, tyrosine kinase inhibitors (TKIs), as well as external beam radiation. However, these can be of limited utility with advanced disease. There is therefore a great need to understand the mechanisms that underlie TC development and progression. For this we can employ molecular analysis approaches, for example using differential expression of genes (DEG) to discover factors involved in dysregulation of cell functions and metabolic pathways that may underlie morbidity and comorbidity [20] , [22] . The repertoire of candidate factors can be extended using approaches such as gene ontology anal-ysis and protein-protein interactions (PPI) studies. Diseases and disease processes can be functionally connected if they involve with the same dysregulated genes or gene pathways.
For identifying DEGs in pathological and normal tissues, microarray gene expression profiling is widely used [9] and several such studies have been performed in TC [30] . For example, Huang et al. [12] studied gene expression profiles of TC patients but addressed only transcript data, while functional interactions among the gene products were not considered. To better understand the molecular mechanisms behind diseases and to identify critical biomolecules, integrative analysis within the network medicine context is needed [21] . Candidate TC biomarkers obtained from such studies may be potential therapeutic targets. Such a systems biology approach integrating network statistical and topological analyses of experimental datasets can clarify disease mechanisms [17] . For this reason, in our study, we used such a systems approach to identify TC molecular signatures at miRNA, mRNA, and protein levels, that differ from that of follicular thyroid adenomas, a type of benign thyroid tumour. Such a comparison is much more meaningful than a comparison of TC to normal thyroid tissue as the tumours are similar while differing markedly in their malignant behaviour. In the present work, the advances in these signaling pathways, ontology enrichment analysis, molecular signatures and targeted treatments of thyroid cancer were reviewed ( Figure 1 ).
II. MATERIALS AND METHODS
In this study, the multi-step analysis method we developed and applied is shown in Fig.1 . We statistically analyzed Gene expression datasets to identify the DEGs and their regulatory patterns. We employed DEGs to identify enriched pathways, biological processes and annotation terms (i.e., Gene Ontology terms) by using functional enrichment methods. Then, to identify reporter biomolecules, We integrated the intermediate analysis results with biomolecular networks.
Dataset Employed and Statistical Methods Used
We obtained the gene expression data of TC (GSE82208) for our study from the NCBI Gene Expression Omnibus (GEO) (http://www.ncbi.nlm.nih.gov/geo/) [4] . The data included analyses of patients of different age and sex. We performed several rounds of filtering, normalization and statistical analysis. To identify genes that was differentially expressed in patients, Students unpaired t-test was performed. To identify a gene as DEG a threshold of at least a 2-fold change in expression levels, and a p-value < 0.05 for the t-tests were chosen.
Functional Enrichment of Gene Sets
We performed gene ontology and pathway analysis on identified DEGs using the David bioinformatics resources (https://david-d.ncifcrf.gov/) (version v6.8) [34] to get further insight into the molecular pathways of TC. In these analyses, Gene Ontology (GO) terminology and KEGG pathway databases were used as annotation sources. Enrichment results Fig. 1 : The multi-stage analysis methodology was employed in this study. Gene expression datasets related to TC were collected from the NCBI Gene Expression Omnibus (NCBI-GEO) database. The dataset was statistically analyzed using GEO2R to identify DEGs. Four types of functional enrichment analyses of DEGs were then performed to identify significantly enriched pathways. Thus, we constructed protein-protein interaction networks around DEGs topological analyses to identify putative pathways hub proteins, identified possible micro-RNA (miRNA) and transcriptions factor (TF) interactors, and used Gene Ontology annotation terms to provide pathways enrichment. TF and miRNA studies employed JASPAR and miRTarbase databases, respectively. DEGs were integrated with those networks and higher degree and betweenness centrality was used to designate TFs and miRNAs as the reporter transcriptional regulatory elements. The target DEGs of reporter miRNAs and TFs were subjected to pathway enrichment analyses.
showing an adjusted p − value < 0.05 were considered significant.
Construction and Analysis of Protein-Protein Interaction (PPI) Sub-networks
The PPI network was first constructed with the DEGs and analyzed using STRING [35] a web-based visualization software resource. The constructed PPI network was represented as an undirected graph, where nodes represent the proteins and the edges represent the interactions between the proteins. The PPI network was then visualized and analyzed using Cytoscape (v3.5.1) [33] . Topological analysis was applied to identify highly connected proteins (i.e., hub proteins) through the Cyto-Hubba plugin [7] . The top three modules (i.e., the three most highly interconnected protein clusters) in the PPI subnetwork were identified using the MCODE plug-in [7] . These modules were further analyzed and characterized using enrichment analyses by NetworkAnalyst [38] . The KEGG pathway enrichment analysis of the PPI networks involved DEGs were performed by NetworkAnalyst [38] .
Identifying TFs and miRNAs that Influence Expression of Candidate Genes
To identify TFs and miRNAs that affect transcript levels around which significant changes occur at the transcriptional level, we obtained experimentally verified TF-target genes from the JASPAR database [15] and miRNA-target gene interactions from TarBase [32] and miRTarBase [11] by using NetworkAnalyst tools [38] .
III. RESULTS AND DISCUSSION

A. Results of DEG analyses Transcriptomic signatures: Differentially expressed genes
Compared to normal subjects, the TC patient gene expression patterns were analysed using oligonucleotide microarrays from the NCBI GEO (http://www.ncbi.nlm.nih.gov/geo/query/acc.cgi?acc=GSE82208) [37] . Gene expression profiling was performed in 27 malignant follicular thyroid cancers and 25 follicular thyroid adenomas. In this analysis, it was found that 598 genes (p < 0.05, > 1.0 log2 fold change) were differentially expressed as compared to controls (follicular thyroid adenomas), amongst which 465 genes were significantly down-regulated and 133 genes were up-regulated (see Additional file 1: Table S1 ).
B. Pathway and functional correlation analysis
Combining large scale, state of the art transcriptom and proteome analysis, we have performed a regulatory analysis to gain further insight into the molecular pathways associated with the TC and predicted links to the affected pathways. DEGs and pathways were analysed using KEGG pathway database (http : //www.genome.jp/kegg/pathway.html) and functional annotation analysis tool DAVID v 6.8 (http://niaid.abcc.ncifcrf.gov) to identify overrepresented pathway groups amongst DEGs and to group them into functional categories. It was observed that four significant pathways, including the "One carbon pool by folate" pathway, p53 signaling pathway, cell cycle and progesterone-mediated oocyte maturation signaling pathway. These are associated with the significantly up-regulated genes of TC. Fold enrichment, adjusted p-values and genes associated with these pathways are presented in the table Table I (a) A. It was also observed that eight pathways were significantly over-represented, including mineral absorption, thyroid hormone synthesis, pathways in cancer, estrogen signaling, sphingolipid metabolism, protein processing in endoplasmic reticulum, axon guidance and focal adhesion pathways (Table I (a) B) were identified. These are associated with the significantly down-regulated DEGs in TC. We then performed gene ontology analysis using DAVID to obtain further insight into the molecular roles and biological function of DEGs in TC. From this analysis, nine gene ontology groups were associated with the significantly upregulated DEG (see Table II (a)) and eighty GO groups were associated with the DEG significantly down-regulated in our TC dataset, the ten most significant gene ontology groups are presented in Table II (a). Fold enrichment, adjusted p-values and genes associated with these ontologies are also indicated.
Proteomic signatures: Hub target proteins from PPI analysis
The protein-protein interaction network was constructed with the DEGs (Fig. 2 A. ) by using STRING. Topological analysis using STRING and further anlysis by Cytoscape's Cyto-Hubba plugin identified the most significant hub proteins, which were identified as gene products of TOP2A, JUN, EGFR, CDK1, FOS, CDKN3, EZH2, TYMS, PBK, CDH1, UBE2C and CCNB2. The simplified protein-protein interaction network for most significant hub genes were constructed by using Cyto-Hubba plugin and shown in fig. 2B . The PPI network was analyzed by using MCODE plug-in in Cytoscape (version 3.5.1), and top three modules were selected (Fig. 3) . The enrichment analysis of the top three modules was analyzed by using DAVID. Module 1 represented a set of biological processs significantly enriched for ATP binding, cell division, cell proliferation; associated enriched cellular components were kinetochore, condensed chromosome kinetochore, I: (a) A. Pathways associated with the significantly genes showing up-regulated expression in TC. The set of significantly up-regulated genes for TC showed an enrichment of four KEGG pathways using DAVID. (a) B. Pathways associated with significantly down-regulated genes of TC. The set of significantly down-regulated genes for TC showed in an enrichment of eight KEGG pathways using DAVID. Fold enrichment, adjusted p-values and genes associated with these pathways are presented in the 2) miRNA regulatory network construction and enrichment analysis of miRNA: We constructed TC DEG-miRNA interactions networks using NetworkAnalyst (Fig. 5 ). By topological analysis, the top 10 ranked miRNAs by highest degree and betweenness centrality were selected which includes hsa-mir-335-5p, hsa-mir-26b-5p, hsa-mir-124-3p, hsa-mir-16-5p, hsamir-192-5p, hsa-mir-1-3p, hsa-mir-17-5p, hsa-mir-92a-3p, hsamir-215-5p, and hsa-mir-20a-5p. The analysis indicates that these are miRNAs having the highest potential to regulate levels of the DEG transcripts. The pathway enrichment analysis of the miRNA associated DEGs networks identified the p53 signaling pathway, Dorso-ventral axis formation, Pertussis, Adherens junction, Thyroid cancer, Pathways in cancer, Focal II: (a) Gene ontologies associated with the up-regulated significant genes of TC. (b) Gene ontologies associated with the down-regulated significant genes of TC. Ten most significant biological functional ontologies are identified that are associated with these significant genes. Fold enrichment, adjusted p-values and genes associated with these ontologies are presented in these tables.
Go Term Pathway
Genes in the pathway adhesion, Sphingolipid metabolism, PPAR signaling pathway, and ECM-receptor interaction signaling system statistically significant (Table IV (a)) IV. DISCUSSION:
To clarify the molecular mechanisms that underlie the pathological features TC, differential gene expression between TC lesions and benign lesions were examined. Note that a strength of this dataset is that comparing malignant follicular TC with benigh follicular adenoma is more meaningful than comparing TC to the more complex normal thyroid tissue where follicular cells form only a minority of cells. The DEGs identified were used to identify possible regulatory patterns, molecular key pathways, and protein-protein interactions. This approach can be used to find molecular signatures that may serve either as potential therapeutic targets or as biomarkers to differentially diagnose or identify TC. We identified a number of significantly altered genes that are candidate signature genes for TC. However, another important use of such data is to identify and characterize biological functions associated with these genes that may give insights into the biology and behavior of TC lesions themselves. Disease genes play a central role in the human interactomes through the pathways. In this study, We found four important pathways that are associated with the thyroid cancer up-regulated genes and eight with the significantly down-regulated genes in TC. The p53 signaling pathway plays an important role in cancer cell apoptosis and DNA repair by causing cycle arrest [41] . Cell cycle progression is facilitated by cyclin-dependent kinases that are activated by cyclins including cyclin D1. The cyclin D1 expression may play a role in tumor progression and may have prognostic significance in TC [36] . One published study confirmed that thyroid cancer is actively associated with the p53 signaling pathway [10] .Another study indicated that abnormal p53 activation is closely related to the development of TC [25] . It was seen that one-carbon metabolism pathways is actively involved in cancer [23] .
We also found that nine important gene ontology groups are associated with the significantly up-regulated genes and eighty important gene ontology groups are associated with the significantly down-regulated genes for TC where top ten are shown in table II. To understand the central mechanisms behind the disease mechanisms, PPI network reconstruction and analysis of reconstructed PPI network represent a powerful approach. For this reason, to construct a PPI network around DEGs for our study, we have combined results of statistical analyses with the protein interactome network. For finding hub proteins, topological analysis strategies were employed. From the PPI network analysis, it was observed that 12 hub genes (Table I (b)) are involved in the TC and relevant diseases. Among the hub genes TOP2A is involved in the thyroid cancer, breast cancer, andon-small cell lung cancers [28] . The hub gene JUN is linked to different types of mitral valve disease (MVD), including mitral regurgitation (MR) and mitral stenosis (MS) [6] . From gene ontology, we found that JUN gene actively in Angiogenesis, positive regulation of endothelial cell proliferation (Table- II (b) ). The hub protein EGFR is implicated in cardiovascular diseases and thyroid cancer [31] and is linked to growth in many types of cancers. The hub gene CDK1 involved in the breast Cancer and ovary carcinoma [18] . CDK1 overexpression has been documented in lung cancer, lymphoma and advanced melanoma and loss of cytoplasmic CDK1 predicts poor survival and confers chemotherapeutic resistance in the latter [27] . Cyclin B1 (in the same family as CDK1) overexpression and/or mislocalization has been described in several primary cancers including thyroid carcinoma, colon, gastric, prostate, breast, and non small-cell lung cancer [27] . It is also actively involved in mitotic cell cycle phase transition ( table-II (a)). The hub gene FOS family is made up four members: c-FOS, FOSB, FOS-like antigen (FOSL) -1 and -2. Generally, the FOSL-2 is connected with the motility, cell adhesion, invasiveness and metastasis than cell growth. This gene is associated with the tumorigenesis of breast cancer, colorectal, and also associated with TC [16] . The hub gene CDKN3 was over expressed in lung adenocarcinoma (ADC), squamous cell carcinoma (SCC), hepatocellular carcinoma, cervical cancer and epithelial ovarian cancer [40] . Over expression of EZH2 is frequently observed in multiple cancer types, including gastric, esophageal, bladder, prostate, breast, ovarian, pancreatic, kidney, liver, brain, and lung cancer and melanoma [39] . The gene TYMS is associated with risk of development of breast cancer, colorectal, lung, pancreatic, gastric, and lymphoma cancer [14] . The gene PBK was found to be over-expressed in haematological and breast tumours and in poorly differentiated thyroid carcinomas (PDTC) cell lines [29] . Besides Hereditary diffuse gastric cancer (HDGC), The hub gene CDH1 mutations are connected with an increased incidence of lobular carcinoma of the breast and, possibly, prostate cancer and colorectal carcinoma [26] . This gene is also involved in extracellular matrix organization (Table-II  (b) ). Previous studies have reported overexpression of UBE2C in some cancers such as colorectal carcinoma, pancreatic carcinoma, cervical cancer, bladder carcinoma, esophageal squamous cell carcinoma and lung cancer, etc. [19] . Hub gene CCNB2 is known to be underexpressed in thyroid cell tumors [8] . We found that CDK1 and CCNB2 hubs genes actively involved in p53 signaling pathway, Progesteronemediated oocyte maturation and Cell cycle pathways. The hub gene TYMS involved in One carbon pool by folate pathway, FOS, JUN and CDH1 genes involved in Pathways in cancer and JUN, FOS genes in Estrogen signaling pathway. By considering the possible roles of these hub proteins in pathogenesis of TC and other related diseases, we suggest further work may identify new roles for these proteins.
As we know that the regulation of gene expression is controlled by TFs and miRNAs at post-transcriptional and/or transcriptional levels, so changes in these molecules may provide crucial information on dysregulation of gene expression in the TC. Therefore, reporter miRNAs and TFs, and their target DEGs have been found out.
Reporter TFs and their relationship to DEGs were analysed ans the top ten TFs selected (Table I (b)). One previous study evaluated that FOXC1 strongly associated with TC [5] . One study found the overexpression of YY1 in differentiated thyroid cancer [2] . The pathway analysis of this TFs regulated DEGs were statistically significant with TC and relevant diseases. From the DEGs-miRNA interaction network top ten miRNA (Table I(b)) were selected and analysed. The pathway analysis of this miRNA regulated DEGs were statistically significant with the thyroid cancer and relevant diseases. It was obtained that the target DEGs of the reporter miRNAs and TFs were involved in p53 signaling pathway, PPAR signaling pathway, Dorso-ventral axis formation, Focal adhesion (Table- IV(a)) and Pathways in cancer, Transcriptional misregulation in cancer,Thyroid cancer, respectively.
V. CONCLUSIONS
Our data-driven approaches are useful for the identification of disease mechanism in a quantitative way. In this study, using integrated bioinformatics analyses, we analyzed gene expression profiles in the TC. Candidate hub proteins identified in this study may play significant roles in the pathogenesis of TC, and indicate focuses for future experimental work to clarify the roles of these proteins. This study provides networks between the genes for understanding the pathogenic properties of TC and maps significant pathways for the future development of novel therapeutic strategies. Our study thus identifies new perspectives in the molecular mechanism for TC that may lead to new potential therapeutic development.
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